H. Lundbeck A/S
HLUN A
ISIN DK0061804697 / Valor 119252584
H. Lundbeck A/S
UMushroom community rating:
About company
H. Lundbeck A/S is a global pharmaceutical company headquartered in Denmark, with a presence in over 50 countries. The company specializes in developing and distributing innovative treatments for brain diseases, leveraging its production facilities in Denmark, France, and Italy, and research centers in Denmark and the United States. Since its listing on Nasdaq Copenhagen in 1999, Lundbeck has been primarily owned by the Lundbeck Foundation, which holds approximately 70% of its shares and supports medical research and educational initiatives. With a history spanning over 70 years, Lundbeck has been instrumental in providing therapies that address neurological and psychiatric disorders, impacting millions of patients worldwide.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
1092 M
Market cap (USD)
75,286
Daily traded volume (Shares)
34 / 33.375
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
